Question 1

What are the potential benefits of participating in this trial compared to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Double-masked Study of PG324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension clinical trial (NCT02558400). Contact the study team or your healthcare provider for specific answers.

Question 2

How will my eye pressure be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Double-masked Study of PG324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension clinical trial (NCT02558400). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I be aware of with PG324 and the other treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Double-masked Study of PG324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension clinical trial (NCT02558400). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit the clinic during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Double-masked Study of PG324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension clinical trial (NCT02558400). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects or complications during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Double-masked Study of PG324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension clinical trial (NCT02558400). Contact the study team or your healthcare provider for specific answers.

Question 6

Will I have the option to continue using PG324 after the trial ends?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Double-masked Study of PG324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension clinical trial (NCT02558400). Contact the study team or your healthcare provider for specific answers.

What this study is about